Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
0.00CNY
4.89 MCNY
10.02 BCNY
772.03 M
About NORTH CHINA PHARMACEUTICAL COMPANY. LTD
Sector
CEO
Xin Yan Liu
Headquarters
Shijiazhuang
Website
Employees (FY)
10.16 K
Founded
1992
ISIN
CNE000000D16
FIGI
BBG000BKC6P8
North China Pharmaceutical Co., Ltd. engages in the research, development, production and sales of pharmaceutical products. It offers chinese and western medicines, antibiotics, vitamins, agricultural, biotechnology products, and veterinary drugs, general freight and technical consulting services. The company was founded on August 25, 1992 and is headquartered in Shijiazhuang, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 600812 is 4.85 CNY — it has increased by 2.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange NORTH CHINA PHARMACEUTICAL COMPANY. LTD stocks are traded under the ticker 600812.
NORTH CHINA PHARMACEUTICAL COMPANY. LTD is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
600812 stock is 3.62% volatile and has beta coefficient of 1.26. Check out the list of the most volatile stocks — is NORTH CHINA PHARMACEUTICAL COMPANY. LTD there?
Yes, you can track NORTH CHINA PHARMACEUTICAL COMPANY. LTD financials in yearly and quarterly reports right on TradingView.
600812 stock has risen by 7.78% compared to the previous week, the month change is a 4.08% rise, over the last year NORTH CHINA PHARMACEUTICAL COMPANY. LTD has showed a 16.81% decrease.
600812 net income for the last quarter is −23.08 M CNY, while the quarter before that showed 1.43 M CNY of net income which accounts for −1.72 K% change. Track more NORTH CHINA PHARMACEUTICAL COMPANY. LTD financial stats to get the full picture.
Today NORTH CHINA PHARMACEUTICAL COMPANY. LTD has the market capitalization of 7.93 B, it has increased by 3.90% over the last week.
Like other stocks, 600812 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NORTH CHINA PHARMACEUTICAL COMPANY. LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 10.16 K employees. See our rating of the largest employees — is NORTH CHINA PHARMACEUTICAL COMPANY. LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NORTH CHINA PHARMACEUTICAL COMPANY. LTD technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NORTH CHINA PHARMACEUTICAL COMPANY. LTD stock shows the sell signal. See more of NORTH CHINA PHARMACEUTICAL COMPANY. LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NORTH CHINA PHARMACEUTICAL COMPANY. LTD EBITDA is 1.42 B CNY, and current EBITDA margin is 14.27%. See more stats in NORTH CHINA PHARMACEUTICAL COMPANY. LTD financial statements.